ArticlePharmaceutics2023

Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus.

Alexander J Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.